Small Molecule Breakthrough

Small Molecule: DCA offers hope to Cancer Sufferers

A recent breakthrough in nanotechnology molecule technology has promising results for cancer sufferers. According to a report by University of Alberta, the molecule acts as a regression agent towards cancer cells.

The best part of this DCA is that it does not have any side effects on non cancerous and normal tissues. This contradicts the conventional kind of treatment where chemo therapies and radio therapies are killing all the good and bad cells in our body. More....